...
首页> 外文期刊>RSC Advances >Synthesis and anti-tubercular activity of fused thieno-/furo-quinoline compounds
【24h】

Synthesis and anti-tubercular activity of fused thieno-/furo-quinoline compounds

机译:融合的融合噻吩/呋喃 - 喹啉化合物的合成与抗结核活性

获取原文

摘要

A simple route for preparation of 4-substituted thieno/furo[2,3- c ]quinoline compounds is reported in this paper. These compounds were synthesized by using Suzuki coupling between appropriate boronic acid and 2-iodoaniline, followed by reaction with diverse aldehydes in the presence of a catalytic amount of FeCl _(3) . Naphthyridine analogues were also prepared in order to demonstrate the efficacy of the developed method. Further anti-tubercular activity screening of the molecules was undertaken, wherein compounds bearing a fused furo[2,3- c ][1,8]naphthyridine skeleton displayed highest activity. The best MIC (minimum inhibitory concentration) value of 5.6 μmol was obtained for 4-(4-methoxyphenyl)furo[2,3- c ][1,8]naphthyridine, which is found to be superior to the existing first line anti-tubercular drug ethambutol (7.6 μmol).
机译:本文报道了一种制备4-取代的Thieno / Furo [2,3- C]喹啉化合物的简单途径。通过在适当的硼酸和2-碘苯胺之间使用铃木偶联来合成这些化合物,然后在催化量的FECL _(3)存在下与各种醛反应。还制备了萘吡啶类似物以证明所发育方法的功效。进行分子的进一步抗结核活性筛选,其中轴承稠合呋喃的化合物[2,3-c] [1,8]萘吡啶骨架显示出最高的活性。获得4-(4-甲氧基苯基)呋喃[2,3-C] [1,8]萘啶的最佳麦克风(最小抑制浓度)值为5.6μmol,该萘啶酮含量优于现有的第一线抗 - 结核药物乙胺醇(7.6μmol)。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号